Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Astria Therapeutics, Inc. (ATXS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K/A10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.50.40.1
            Revenue growth      -100.0%33.0%276.0% 
Cost of goods sold  0.00.00.00.00.00.00.40.1
Gross profit  0.00.00.00.00.00.50.00.0
            Gross margin       100.0%0.0%0.0%
Selling, general and administrative   [+]19.214.811.88.89.38.910.18.6
Research and development  34.315.625.618.317.018.725.523.0
Other operating expenses   0.9      
EBITDA   [+]    -26.3-26.8-35.2-31.5
            EBITDA margin       -5358.0%-9351.9%-31457.0%
Depreciation and amortization      0.10.30.40.2
EBIT   [+]-53.5-31.2-37.4-27.1-26.4-27.1-35.6-31.7
            EBIT margin       -5418.8%-9456.9%-31659.0%
Non-recurring items   [+] 163.8      
Interest income, net   [+]1.70.10.20.80.4-0.3-0.6-1.0
Other income (expense), net  -0.1-0.1-0.10.00.10.00.10.0
Pre-tax income  -51.8-194.9-37.3-26.3-25.9-27.4-36.1-32.6
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -51.8-219.3-37.3-26.3-25.9-27.4-36.1-32.6
            Net margin       -5472.8%-9590.4%-32630.0%
   
Basic EPS   [+]($3.55)($24.58)($12.20)($2.35)($5.12)($12.62)($2.22)($4.06)
Diluted EPS   [+]($3.55)($24.58)($12.20)($2.35)($5.12)($12.62)($2.22)($4.06)
   
Shares outstanding (basic)   [+]14.68.93.111.25.12.216.28.0
Shares outstanding (diluted)   [+]14.68.93.111.25.12.216.28.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy